Our Blog Melanoma360

Blog - Melanoma360

Featured image for “The Clinical Trial Experience: A Patient’s Perspective”
12/18/2023

The Clinical Trial Experience: A Patient’s Perspective

In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
Blog - Melanoma360
Podcast
Featured image for “Celebrate Survivorship – Give Towards Melanoma Research”
12/05/2023

Celebrate Survivorship – Give Towards Melanoma Research

Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
Blog - Melanoma360
Philanthropy
Featured image for “Melanoma Cancer and Financial Toxicity”
11/14/2023

Melanoma Cancer and Financial Toxicity

While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
Blog - Melanoma360
Podcast
Featured image for “National Family Caregiver Month”
10/31/2023

National Family Caregiver Month

National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
Blog - Melanoma360
Friends, Family, & Caregivers
Featured image for “Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial”
10/23/2023

Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma”
10/15/2023

Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma

October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “That Good Night: Life and Medicine in the Eleventh Hour”
10/13/2023

That Good Night: Life and Medicine in the Eleventh Hour

A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
Blog - Melanoma360
Podcast
Featured image for “Notes from the Lab: Novel targets for immune checkpoint inhibitors”
09/17/2023

Notes from the Lab: Novel targets for immune checkpoint inhibitors

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
Blog - Melanoma360
Melanoma Research
Featured image for “Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
09/12/2023

Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
Blog - Melanoma360
Podcast
Featured image for “In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here”
09/07/2023

In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here

By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
Blog - Melanoma360
In Plain English
12/18/2023

The Clinical Trial Experience: A Patient’s Perspective

In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
Featured image for “The Clinical Trial Experience: A Patient’s Perspective”
Blog - Melanoma360
 | 
Podcast
12/05/2023

Celebrate Survivorship – Give Towards Melanoma Research

Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
Featured image for “Celebrate Survivorship – Give Towards Melanoma Research”
Blog - Melanoma360
 | 
Philanthropy
11/14/2023

Melanoma Cancer and Financial Toxicity

While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
Featured image for “Melanoma Cancer and Financial Toxicity”
Blog - Melanoma360
 | 
Podcast
10/31/2023

National Family Caregiver Month

National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
Featured image for “National Family Caregiver Month”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
10/23/2023

Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
Featured image for “Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
10/15/2023

Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma

October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
Featured image for “Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
10/13/2023

That Good Night: Life and Medicine in the Eleventh Hour

A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
Featured image for “That Good Night: Life and Medicine in the Eleventh Hour”
Blog - Melanoma360
 | 
Podcast
09/17/2023

Notes from the Lab: Novel targets for immune checkpoint inhibitors

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
Featured image for “Notes from the Lab: Novel targets for immune checkpoint inhibitors”
Blog - Melanoma360
 | 
Melanoma Research
09/12/2023

Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
Featured image for “Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
Blog - Melanoma360
 | 
Podcast
09/07/2023

In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here

By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
Featured image for “In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here”
Blog - Melanoma360
 | 
In Plain English